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Abstract
Background
Among U.S. residents, tuberculosis (TB) disease disproportionally affects non-U.S.-born
persons and varies substantially by country of birth. Yet TB disease incidence rates by coun-
try of birth are not routinely reported despite these large, known health disparities. This is in
part due to the technical challenges of using standard regression analysis with a communi-
cable disease. Here, we estimate tuberculosis disease incidence rates by country of birth
and demonstrate methods for overcoming these challenges using TB surveillance data from
Los Angeles County which has more than 3.5 million non-U.S.-born residents.
Methods
Cross-sectional data on 5,447 cases of TB disease from Los Angeles County were com-
bined with population estimates from the American Community Survey to calculate TB dis-
ease incidence rates for 2005 through 2011. Adjusted incidence rates were modelled using
Poisson and negative binomial regressions. Bayesian models were used to account for the
uncertainty in population estimates.
Results
The unadjusted incidence rate among non-U.S.-born persons was 15 per 100,000 person-
years in contrast to the rate among U.S-born persons, 2 per 100,000. The unadjusted inci-
dence rates were 44 and 12 per 100,000 person-years among persons born in the Philip-
pines and Mexico, respectively. In adjusted analysis, persons born in the Philippines were
2.6 (95% CI: 2.3–3.1) times as likely to be reported as a TB case than persons born in
Mexico. Bayesian models showed similar results.
PLOS ONE | https://doi.org/10.1371/journal.pone.0209051 December 18, 2018 1 / 12
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Readhead A, Chang AH, Ghosh JK,
Sorvillo F, Detels R, Higashi J (2018) Challenges
and solutions to estimating tuberculosis disease
incidence by country of birth in Los Angeles
County. PLoS ONE 13(12): e0209051. https://doi.
org/10.1371/journal.pone.0209051
Editor: David J. Horne, University of Washington,
UNITED STATES
Received: August 20, 2018
Accepted: November 27, 2018
Published: December 18, 2018
Copyright: © 2018 Readhead et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Data cannot be
shared publicly because they contain sensitive
personal health information that is protected by the
federal HIPAA Privacy Rule. Data are available from
the Los Angeles County Department of Public
Health TB Control Program for researchers who
meet the criteria for access to confidential data.
Funding: The authors received no specific funding
for this work.
Competing interests: The authors have declared
that no competing interests exist.
Conclusion
This study confirms substantial disparities in TB disease by country of birth in Los Angeles
County. Accounting for age, gender, years in residence and year of diagnosis, persons from
the Philippines, Vietnam and several other countries had much higher rates of reported TB
disease than other foreign countries. We demonstrated that incidence rates by country of
birth can be estimated using available data despite technical challenges.
Introduction
Tuberculosis (TB) is a global public health threat with more than one-quarter of the world’s
population infected with Mycobacterium tuberculosis and, in 2016, more than 10.4 million
incident cases [1, 2]. In the U.S., there were 9,272 reported TB cases in 2016, of which 69%
were among non-U.S.-born persons [3]. Estimation of TB incidence by country of birth is
especially important in Los Angeles County which is home to 3.5 million who were born out-
side the U.S.; the largest number of non-U.S.-born persons within a single U.S. county [4, 5].
Earlier studies have shown substantial disparities in TB disease incidence by country of birth
both in Los Angeles County and domestically [6, 7]. Only by describing health disparities can
we achieve the Federal Department of Health and Human Services’ goal of eliminating them
[8].
Yet these analyses did not produce incidence rates adjusted for important confounders
such as age, gender and years in residence, in part due to the technical challenges of using stan-
dard regression analysis with a communicable disease [9]. Standard count models assume that
outcome events are independent, however communicable disease events are by definition
dependent. Each case occurs because they were infected by another case. When using count
models with communicable disease, additional attention is needed to ensure that the violation
of the independence assumption does not undermine the validity of the model. Furthermore,
because population estimates used in calculating incidence are commonly derived from a sur-
vey, survey error needs to be accounted for. Finally, the demographics of Los Angeles County
have changed since the last study of TB incidence by country of birth in Los Angeles in 1996
[7]. The proportion of non-U.S.-born persons increased slightly from 33% in 1990 to 36% in
2000 and remained stable at 36% in 2010 [10–12]. The median age increased from 30.6 in 1990
to 32.0 in 2000 and continued to increase to 34.8 in 2010 [10, 13–15]. Here we describe unad-
justed and adjusted TB disease incidence rates by country of birth in Los Angeles County and
demonstrate incidence rate estimation accounting for survey error in the population estimates
used and potential violations of the independence assumption that occur when standard count
models are used with a communicable disease.
Materials and methods
Data sources
Data on 5,447 reported verified cases of tuberculosis reported between January 1, 2005 through
December 31, 2011 were drawn from the tuberculosis surveillance database of the Los Angeles
County Department of Public Health Tuberculosis Control Program (TBCP). California medi-
cal providers are required by state law to report persons with suspected or confirmed active TB
disease and provide demographic and clinical information for these patients to the local health
jurisdiction [16, 17]. TBCP staff verify the case by reviewing laboratory, microbiology, and
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radiographic results or other clinical information, and may request additional diagnostics.
This study was deemed exempt by the Los Angeles County Department of Public Health Insti-
tutional Review Board. Tuberculosis case data contain sensitive personal health information
that is protected by the federal HIPAA Privacy Rule and cannot be publicly shared. Applica-
tion for access should be addressed to the Los Angeles County Department of Public Health
TB Control Program.
Data used to create stratified population estimates were obtained from the Public Use
Microdata Survey (PUMS), a subsample of American Community Survey (ACS) data,
designed to allow custom stratifications otherwise unavailable in U.S. Census reports [18, 19].
Population estimates by country of birth are also available in table B05006 from the U.S. Cen-
sus which can be accessed through American Factfinder S1 File [20]. The ACS used two sam-
pling frames: housing units and group quarters. Housing unit addresses were sampled from
the Census Bureau’s master address file and the number of persons living in each unit was
ascertained; survey weights were derived from the sampling probabilities [21]. Sampling for
group quarters was similar [21]. Population estimates were calculated using survey weights
and confidence intervals for these estimates were calculated using replicate weights [22].
Detailed county-level numerator data were derived by aggregating data from sub-county areas
called Public Use Microdata Areas (PUMAs) which are defined by PUMS. PUMS began pub-
lishing data at the PUMA level in 2005, which meant that detailed numerator data at the
county level was only available starting in 2005. PUMAs are redrawn with every census and
the methodology for PUMA changed substantially with the 2010 Census. Because the 2010
Census results were delayed, PUMAs were defined consistently from 2000–2011. The analysis
end date of 2011 was decided on to avoid issues stemming from changes in PUMA definitions.
Inclusions and exclusions
Beginning in 2006, the ACS sampling frame included institutional and non-institutional
group quarters as defined by the U.S. Census Bureau. This group quarters definition includes
Federal and state correctional facilities, local jails, homeless shelters and long-term care facili-
ties among others. In 2005 and prior years, group quarters were not included [23]. To ensure
that the numerator data matched this change in denominator data, we made the following
exclusions: cases residing in correctional facilities or long-term care were excluded if they were
reported in 2005 but were included if they were reported between 2006 and 2011; cases
reported as homeless were excluded except for those reported between 2006 and 2011 who
were living in a homeless shelter. The ACS only enumerated homeless persons who live in
homeless shelters, not those living on the street or in encampments. We excluded a total of 494
(9%) cases in the following categories: 277 cases that were homeless and not housed in home-
less shelters (group quarters), 49 cases reported in 2005 that were living in group quarters, 112
cases that were non-U.S.-born and missing date of arrival in the U.S., 26 cases with missing
country of birth, 15 cases with countries of birth not enumerated by ACS in the study period,
14 cases diagnosed in other counties but transferred to Los Angeles County for follow-up, and
1 case that could not be assigned to a PUMA. A total of 4,953 cases were available for unad-
justed analysis. To accommodate the inclusion of years in residence in the U.S. in multivari-
able models, the data were further limited to non-U.S.-born cases, leaving 3,945 cases for
adjusted analyses. Years in residence was found to be strongly associated with TB incidence in
previous studies [6]. As age was included in most models, we opted not to substitute age for
years in residence for U.S.-born cases as this would introduce collinearity into the regression.
Cases residing in the cities of Long Beach or Pasadena were not included as those cases are not
reported to the Los Angeles County Department of Public Health.
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Data definitions
Data on cases born in South Korea and North Korea were combined into a single category,
Korea, to match the ACS. Age was defined as age at diagnosis. Years in residence was defined
as the difference in years between the arrival date and the diagnosis date. Report date was
defined as the date the case was confirmed. Isoniazid mono-resistance was defined as resis-
tance to isoniazid only; multi-drug resistance (MDR) was defined as resistance to isoniazid
and rifampicin with or without resistance to additional TB medications. Extensively drug-
resistant tuberculosis (XDR) was defined as meeting the MDR definition as well as resistance
to “any fluoroquinolone and at least one of three injectable second-line drugs.” [24, 25]. Cul-
ture positive was defined as a positive culture from sputum collected within 15 calendar days
of the start of treatment (if treatment was reported) or within 15 calendar days of diagnosis (if
treatment was not reported) [26]. The reference category for country of birth was set as
Mexico.
Analysis
Using a cross-sectional design for the period 2005–2011, we calculated unadjusted incidence
rates and standard confidence intervals using the number of TB cases and the estimated popu-
lation stratified by country of birth. Confidence intervals for unadjusted rates likely understate
the variability of the estimate because data were over-dispersed. In a Poisson model, the mean
and variance are equal; over-dispersion is defined as when the variance is larger than the mean
[27]. Relative standard error was calculated as 1ffiffinp where n is the number of cases. We fit gener-
alized linear models (GLMs) based on Poisson and negative binomial distributions, acknowl-
edging that data with correlated outcomes, such as TB, are commonly over-dispersed. We
monitored over-dispersion in our models via the dispersion statistic. We selected country of
birth, age, gender, years in residence and year of report as covariates a priori based on evidence
in previous literature and on availability in TB surveillance and PUMS data [6, 7, 28]. Robust
confidence intervals were calculated per Hilbe [9].
To account for uncertainty in population estimates, we adopted a Bayesian framework and
introduced probability distributions, or priors, for these estimates. First, we constructed Bayes-
ian analogues to Poisson and negative binomial GLMs. Bayesian models were fitted using R,
OpenBUGS, and nimble [29–31]. Standard BUGS coding was used S2 File. Priors for the inter-
cept and all covariate coefficients were defined to be N(0,1000). All covariates were categorical
and had corner constraints on the reference category. For the negative binomial Bayesian
model, the prior for r was G(1,10). Two MCMC chains were run for 100,000 iterations each.
Reasonable mixing and stability were achieved. Second, we introduced informative priors on
the population estimates, constructed to match the standard errors of these estimates calcu-
lated using replicate weights. The population estimate priors were truncated to [1,1]. This
resulted in a distortion of the prior distribution for some estimates. Analysis was done using
SAS version 9.1.3, R version 3.4, R Studio version 1.0.143 and a variety of R packages S2 File.
Bayesian models were run in OpenBUGS version 3.2.2 rev 1012 [30].
Results
Unadjusted analysis
The TB disease incidence rate was nearly seven times higher among non-US-born persons
(15.8 per 100,000 person-years) than US-born persons (2.3 per 100,000 person-years). How-
ever, among non-US-born persons, there was considerable variation by country of birth. The
incidence rate was highest among persons born in Burma (78.9 per 100,000), Ethiopia (55.9
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per 100,000 person-years), Indonesia (47.4 per 100,000 person-years), the Philippines (44.3 per
100,000) and Vietnam (38.7 per 100,000) Table 1.
Of cases reported in the study period, 64% occurred among persons born in eight countries:
the Philippines, Vietnam, China, India, Korea, Guatemala, Mexico and El Salvador. Among
these eight countries, TB incidence rates ranged from 44.3 per 100,000 person-years (95% CI
41.1–47.5) among persons born in the Philippines to 9.4 per 100,000 (95% CI 8.0–10.8) among
persons born in El Salvador.
The proportion of culture positive cases that were isoniazid mono-resistant was highest
among persons born in the Philippines, Vietnam and India Table 1. The proportion of isonia-
zid resistance ranged from 18% to 20% for active TB cases born in the Philippines, Vietnam or
India. In contrast, the proportion of isoniazid resistance ranged from 3% to 8% for TB cases
Table 1. Unadjusted TB incidence rates by selected country of birth1, Los Angeles County 20052−2011.
Country of Birth Cases Person-Years2 Unadjusted Incidence per
100,000 person-years
95% Confidence
Interval4
Proportion
of Cases
Culture
Positive
Isoniazid
Resistant5
Multidrug
Resistant5
N % N %
Burma (Myanmar) 34 43,072 78.9 (55.5–109.1) 0.7 22 � � � �
Ethiopia 25 44,750 55.9 (37.0–81.3) 0.5 15 � � � �
Indonesia 49 103,480 47.4 (35.4–62.1) 1.0 34 � � � �
Philippines 742 1,674,344 44.3 (41.2–47.6) 15.0 447 90 20.1 13 2.9
Vietnam 265 685,320 38.7 (34.2–43.5) 5.3 168 32 19 � �
India 98 331,396 29.6 (24.1–35.9) 2.0 32 6 18.8 � �
Nigeria 16 56,307 28.4 (16.8–45.2) 0.3 6 � � � �
China 261 942,822 27.7 (24.5–31.2) 5.3 177 11 6.2 6 3.4
Cambodia (Kampuchea) 43 173,988 24.7 (18.1–33.0) 0.9 25 � � � �
Pakistan 12 50,634 23.7 (12.8–40.3) 0.2 5 � � � �
Peru 46 195,596 23.5 (17.4–31.1) 0.9 30 � � � �
Korea 249 1,123,255 22.2 (19.5–25.1) 5.0 180 22 12.2 8 4.4
Honduras 51 234,421 21.8 (16.4–28.4) 1.0 39 � � � �
Thailand 29 155,805 18.6 (12.7–26.4) 0.6 18 � � � �
Guatemala 212 1,207,414 17.6 (15.3–20.0) 4.3 145 12 8.3 � �
Mexico 1,271 10,212,974 12.4 (11.8–13.1) 25.7 750 63 8.4 5 0.7
Taiwan 55 476,938 11.5 (8.8–14.9) 1.1 40 � � � �
Colombia 12 111,087 10.8 (5.9–18.4) 0.2 6 � � � �
El Salvador 173 1,836,839 9.4 (8.1–10.9) 3.5 101 � � � �
Armenia 40 429,402 9.3 (5.7–14.4) 0.8 30 � � � �
Hong Kong 18 193,797 9.3 (6.7–12.6) 0.4 10 � � � �
Nicaragua 15 210,585 7.1 (4.1–11.5) 0.3 11 � � � �
Iran 49 746,784 6.6 (4.2–9.9) 1.0 31 � � � �
Japan 21 317,750 6.6 (4.9–8.6) 0.4 15 � � � �
United States 1,002 43,849,895 2.3 (2.1–2.4) 20.2 464 22 4.7 � �
Source: Los Angeles County Department of Public Health, TB Control Program. Isoniazid resistance is not exclusive of other resistance.
1 Excludes countries where the relative standard error of the incidence estimate is greater or equal to 30%.
2 Person-years were calculated using the ACS Public Use Microdata Survey.
3 For 2005, we excluded cases indicated to be homeless, incarcerated or in long-term care facilities because ACS did not estimate these populations.
4 Confidence intervals were calculated using the mid-p method and are likely to understate the variability of the estimate because data were over-dispersed.
5 The number of culture positive case was used as the denominator for proportions with drug resistance.
� Data in strata with 5 or fewer cases are suppressed.
https://doi.org/10.1371/journal.pone.0209051.t001
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born in Honduras, El Salvador or Mexico. Similar patterns were observed for multi-drug resis-
tant (MDR) cases, though very few countries of birth could be analyzed due to sparse data. Of
cases among persons born in Mexico, 0.7% were MDR, whereas 4.4% of cases among persons
born in Korea were MDR. There were no cases with extensively-drug resistant TB in the analy-
sis period.
Among non-U.S.-born persons, TB disease incidence rates were higher among men and
those residing in the U.S. for less than 1 year; TB disease increased with age Table 2 and S1
Table. Of all non-U.S.-born cases in the study period, 59% were among persons who had
resided in the U.S. for 10 or more years. The overall incidence rate declined from 18.1 per
100,000 in 2005 to 14.0 per 100,000 in 2011. Among the top 8 countries of birth with highest
burden of TB disease, incidence rates declined though rates were variable S2 Table.
Adjusted analysis
Fitting a naïve Poisson GLM confirmed substantial over-dispersion; a Poisson model with
country of birth and offset alone had a dispersion statistic of 10.5. An expanded model includ-
ing country of birth, age, gender, report year and years in residence had notably less over-dis-
persion with a dispersion statistic of 1.5.
Using standard GLMs and adjusting for other factors associated with TB disease incidence
such as age, gender, length of residence and report year, persons born in Vietnam were 2.6
(95% robust confidence interval (RCI) 2.3–3.0) times as likely to have been reported with TB
disease than persons born in Mexico Table 2. Persons born in the Philippines and India were
2.6 (95% RCI 2.3–2.8) and 1.5 (95% RCI 1.2–1.8) times as likely, respectively, to be reported
with TB disease than persons born in Mexico. In contrast, persons born in El Salvador were
0.8 (95% RCI0.6–0.9) times as likely as persons born in Mexico to be reported with TB disease.
Estimates from adjusted Poisson and negative binomial models were similar and had relatively
little over-dispersion Table 2. Both had dispersion statistics close to 1, though the negative
binomial model was a better fit for the data.
We found negligible differences between the standard GLMs and their Bayesian analogues,
though incidence rates estimated using the Bayesian negative binomial model were generally
lower than standard negative binomial regression results Tables 2 and 3. Results from the
Bayesian Negative Binomial model with priors on population estimates were on par with the
Bayes Negative Binomial model which did not account for uncertainty in population estimates
Table 3.
Discussion
This study highlights the large differences in TB disease by country of birth while demonstrat-
ing solutions to common challenges in calculating unadjusted and adjusted TB incidence rates
by country of birth. Earlier studies of TB disease by country of birth did not adjust for age, gen-
der, or length of residence in the U.S., all important cofounders of TB disease risk. Here, we
showed that sizable disparities by country of birth were evident even when adjusting for these
confounders. In the adjusted analysis, persons born in the Philippines or Vietnam were
approximately 3 times more likely than persons born in Mexico to be reported as a case of TB
disease. In contrast, persons born in China, Korea or Guatemala were about 25% more likely
to be reported as a case of TB disease. Overall, TB disease was more than 8 times more likely to
be reported among non-U.S.-born persons than among U.S.-born persons. Previous data in
Los Angeles County from 1996 showed non-U.S.-born persons to be 4 times as likely as U.S.-
born persons to be diagnosed with TB in unadjusted analyses [7]. In the U.S. in 2015, non-U.
S.-born persons were approximately 13 times as likely to be diagnosed with TB as U.S.-born
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persons [32]. Locally, this information can be used to focus population and neighborhood cen-
tered outreach for TB elimination and to ensure this outreach is implemented in a patient cen-
tered manner. Country of birth is helpful in suggesting cultural and linguistic needs of the
target populations. More generally, this analysis addresses three main concerns regarding the
Table 2. Unadjusted and adjusted TB incidence rates and incidence rate ratios by selected country of birth, Los Angeles County 20051−2011.
Unadjusted Adjusted Poisson GLM Adjusted negative binomial GLM
Demographic
Characteristic
Incidence Incidence Rate
Ratio
Standard 95%
CI
Incidence Rate
Ratio
Standard 95%
CI
Robust 95%
CI
Incidence Rate
Ratio
Standard 95%
CI
Robust 95%
CI
Country of Birth
Philippines 44.3 3.56 3.25–3.90 2.56 2.33–2.81 2.29–2.86 2.60 2.31–2.94 2.31–2.93
Vietnam 38.5 3.10 2.71–3.53 2.60 2.27–2.99 2.26–2.99 2.66 2.26–3.13 2.30–3.08
India 29.6 2.38 1.93–2.92 1.47 1.19–1.82 1.16–1.87 1.51 1.20–1.89 1.19–1.92
China 27.7 2.22 1.95–2.54 1.27 1.10–1.45 1.08–1.49 1.26 1.08–1.48 1.07–1.49
Korea 22.2 1.78 1.56–2.04 1.35 1.18–1.55 1.15–1.57 1.36 1.16–1.59 1.15–1.59
Guatemala 17.6 1.41 1.22–1.63 1.27 1.09–1.47 1.06–1.52 1.27 1.07–1.51 1.05–1.53
Mexico 12.4 Reference Reference Reference
Other non-U.S.
country
9.6 0.77 0.70–0.85 0.59 0.54–0.65 0.53–0.67 0.63 0.55–0.71 0.56–0.70
El Salvador 9.4 0.76 0.65–0.89 0.75 0.64–0.88 0.63–0.88 0.75 0.63–0.91 0.64–0.89
Age at Diagnosis
(years)
0–19 6.6 0.46 0.38–0.56 0.19 0.16–0.24 0.16–0.24 0.20 0.16–0.25 0.16–0.25
20–39 12.1 0.85 0.78–0.92 0.58 0.53–0.63 0.52–0.64 0.61 0.55–0.68 0.55–0.68
40–59 14.2 Reference Reference Reference
60–79 25.8 1.81 1.67–1.97 1.87 1.72–2.04 1.70–2.06 1.91 1.72–2.13 1.72–2.13
80–106 49.6 3.49 3.12–3.90 4.13 3.68–4.64 3.65–4.67 4.20 3.66–4.82 3.69–4.78
Gender
Male 18.7 Reference Reference Reference
Female 12.9 0.69 0.65–0.73 0.63 0.59–0.67 0.58–0.68 0.65 0.60–0.70 0.60–0.70
Years in Residence
0–1 109.2 9.22 8.19–10.39 12.4 10.87–14.19 10.48–14.71 12.8 11.05–14.83 10.83–15.14
2–4 31.2 2.64 2.42–2.87 4.35 3.96–4.77 3.92–4.81 4.33 3.87–4.84 3.90–4.81
5–9 17.5 1.47 1.34–1.62 2.30 2.09–2.54 2.06–2.58 2.31 2.06–2.60 2.07–2.59
10–19 13.9 1.17 1.06–1.30 1.65 1.48–1.84 1.46–1.87 1.72 1.52–1.94 1.51–1.95
20–93 11.8 Reference Reference Reference
Year of Diagnosis
2005 18.1 Reference Reference Reference
2006 17.8 0.98 0.88–1.09 1.00 0.90–1.12 0.89–1.13 1.00 0.87–1.15 0.88–1.14
2007 16.4 0.90 0.81–1.01 0.89 0.79–1.00 0.78–1.02 0.90 0.78–1.03 0.78–1.04
2008 15.7 0.86 0.77–0.97 0.86 0.77–0.97 0.75–0.99 0.86 0.74–0.99 0.74–0.98
2010 14.3 0.79 0.70–0.88 0.79 0.70–0.89 0.69–0.90 0.77 0.66–0.89 0.66–0.89
2009 14.0 0.77 0.69–0.87 0.77 0.69–0.87 0.68–0.89 0.75 0.65–0.86 0.65–0.86
2011 14.0 0.77 0.69–0.87 0.78 0.69–0.87 0.68–0.89 0.75 0.65–0.87 0.65–0.87
Dispersion Statistic N/A 1.5 1.4
AIC N/A 6560 6502
Source: Los Angeles County Department of Public Health, TB Control Program & Public Use Microdata Survey via IPUMS.
1 For 2005, we excluded cases indicated to be homeless, incarcerated or in long-term care facilities because ACS did not estimate these populations.
2 Adjusted model includes the following covariates: age, gender, length of residence and year of diagnosis.
https://doi.org/10.1371/journal.pone.0209051.t002
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calculation of TB disease incidence rate by country of birth. First, population estimates by
country of birth can be hard to find. Here we outlined how to access population estimates by
country of birth through American FactFinder and provided information on the use of PUMS
data. Second, some analysts are wary of using survey estimates because of the survey error
associated with these estimates. We addressed this by adding uncertainty into the model in the
form of priors on the population estimates; in this case, increased uncertainty in the popula-
tion estimates had little effect on the model estimates. Third, data on communicable diseases,
such as TB, are typically over-dispersed and difficult to properly model with standard regres-
sion methods. Standard count models assume that outcomes are independent, but in TB, as in
Table 3. TB incidence rate ratios by selected demographic characteristics–adjusted Bayesian models, Los Angeles County 20051−2011.
Demographic Characteristic Poisson Bayes Negative Binomial Bayes Negative Binomial Bayes with priors on population estimates2
Country of Birth
Philippines 2.56 (2.32–2.82) 2.60 (2.27–2.95) 2.61 (2.30–2.95)
Vietnam 2.60 (2.24–2.98) 2.65 (2.21–3.13) 2.64 (2.21–3.12)
India 1.47 (1.17–1.80) 1.50 (1.16–1.89) 1.50 (1.16–1.89)
China 1.26 (1.09–1.45) 1.26 (1.06–1.48) 1.26 (1.06–1.48)
Korea 1.34 (1.16–1.54) 1.35 (1.13–1.59) 1.36 (1.15–1.60)
Guatemala 1.26 (1.08–1.46) 1.27 (1.05–1.51) 1.25 (1.05–1.49)
Mexico Reference Reference Reference
Other non-U.S. country 0.59 (0.54–0.65) 0.63 (0.55–0.71) 0.62 (0.55–0.71)
El Salvador 0.74 (0.63–0.87) 0.75 (0.61–0.90) 0.75 (0.61–0.90)
Age
0–19 0.19 (0.16–0.24) 0.20 (0.16–0.24) 0.20 (0.16–0.24)
20–39 0.58 (0.53–0.63) 0.61 (0.55–0.68) 0.61 (0.55–0.68)
40–59 Reference Reference Reference
60–79 1.87 (1.71–2.04) 1.91 (1.71–2.14) 1.90 (1.69–2.11)
80–106 4.13 (3.65–4.64) 4.20 (3.62–4.83) 4.16 (3.60–4.79)
Gender
Male Reference Reference Reference
Female 0.63 (0.59–0.67) 0.65 (0.60–0.70) 0.65 (0.59–0.70)
Years in Residence
0–1 12.39 (10.77–14.16) 12.79 (10.89–14.91) 12.22 (10.36–14.36)
2–4 4.34 (3.94–4.77) 4.32 (3.83–4.86) 4.37 (3.87–4.90)
5–9 2.30 (2.08–2.54) 2.31 (2.03–2.61) 2.31 (2.04–2.60)
10–19 1.65 (1.48–1.84) 1.71 (1.49–1.95) 1.69 (1.48–1.92)
20–93 Reference Reference Reference
Year of Diagnosis
2005 Reference Reference Reference
2006 1.00 (0.89–1.12) 1.00 (0.86–1.15) 0.99 (0.85–1.14)
2007 0.89 (0.79–1.00) 0.90 (0.77–1.04) 0.89 (0.76–1.02)
2008 0.86 (0.76–0.97) 0.85 (0.73–0.99) 0.85 (0.73–0.98)
2009 0.79 (0.69–0.89) 0.77 (0.65–0.89) 0.77 (0.66–0.89)
2010 0.77 (0.68–0.87) 0.75 (0.64–0.87) 0.75 (0.64–0.87)
2011 0.77 (0.68–0.87) 0.75 (0.64–0.87) 0.75 (0.64–0.87)
Source: Los Angeles County Department of Public Health, TB Control Program & Public Use Microdata Survey via IPUMS.
1 For 2005, we excluded cases indicated to be homeless, incarcerated or in long-term care facilities because ACS did not estimate these populations.
2 Priors on population estimates calculated based on standard error of denominator which in turn was calculated based on PUMS replicate weights.
https://doi.org/10.1371/journal.pone.0209051.t003
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other communicable diseases, outcomes are not independent. However, with the inclusion of
key covariates and use of appropriate diagnostic tests, these models can be used to produce
reasonable estimates. Moreover, dependent outcomes typical of communicable diseases are
less of a concern here because an estimated 85% of TB cases in California result from the reac-
tivation of latent TB infection [33]. These reactivation cases are independent of each other as
reactivation depends on host immune status and co-morbidities, not on recent infection.
The results also indicate a notable decline in TB disease incidence over the study period for
all countries of birth S2 Table. Incidence rates declined for both non-U.S.-born persons and U.
S.-born persons during the study period from 18.1 per 100,000 in 2005 to 14.0 per 100,000 in
2011; similar declines have been seen both nationally and in other cities [28, 32]. Consistent
with previous reports, we observed higher incidence rates among males, older adults and,
most notably, those with fewer years of residence in the U.S Table 3 [6, 7]. Additional risk
among older non-U.S-born adults is likely due to longer periods of exposure in a high-burden
country as well as greater likelihood of reactivation due to a waning immune system. A proxy
indicator of time living in a high burden country would have been age at immigration, which
we did not specifically include as a covariate. However, including both age years in US resi-
dence in models would account for age at immigration indirectly. Though we have tried to
address known and suspected confounders, as with all models, residual confounding most
likely remains and we acknowledge this potential limitation.
While based on mature data collection systems, this study has several limitations. Despite
adjustment, the data remained over-dispersed, which could result in the under-coverage of
confidence intervals, including robust confidence intervals. Confidence intervals also do not
account for unknown or residual confounding or other systematic errors. If the confidence
intervals presented here are too narrow, there may be little difference in the incidence rates of
persons born in India, China, Korea or Guatemala and the reference category, Mexico,
accounting for other covariates. Thus, the differences in TB incidence rates noted here, while
in keeping with published literature, should be confirmed with additional data from other set-
tings. Spatial effects and disease transmission were not taken into consideration. Case ascer-
tainment is unknown though it is thought to be high, similar to other TB surveillance systems
[34–36]. Higher TB disease incidence among recently-immigrated non-U.S. born could be in
part the result of increased ascertainment in this group. Truncation of the population estimate
priors may have inflated some population estimates, but did so minimally, given the similarity
between models with and without these priors. Furthermore, some non-U.S.-born populations
may be under-counted in the ACS; a recent report suggests reasonable survey coverage of
non-Hispanic non-U.S.-born populations but under-coverage of Hispanic non-U.S.-born per-
sons [37].
Conclusions
This study confirms substantial differences in TB disease by country of birth in Los Angeles
County. Even accounting for differences in age, gender, and years in residence distributions,
persons from the Philippines, Vietnam and several other countries have much higher rates of
reported TB disease than persons from other non-U.S. countries. We have demonstrated that
incidence rates by country of birth can be calculated with readily-accessible population esti-
mates and that more complex adjusted estimates can be achieved through the use of negative
binomial models and Bayesian techniques. This analysis helped better describe the local TB
disparities in Los Angeles County and can be used to inform a continued public health
response.
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